View in EDS

Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer.

Saved in:
Bibliographic Details
Title: Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer.
Authors: Sandherr M; German Society of Hematology and Medical Oncology (DGHO), Berlin, Germany. Electronic address: sandherr@dgho.de., Schalk E; Department of Hematology Oncology and Cell Therapy, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany., Heinz WJ; Universtity of Wuerzburg, Wuerzburg, Germany., Köhler P; University of Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany., Krause SW; Department of Medicine 5 - Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany., Liss B; Department of Hematology and Oncology, Infectious Diseases and Palliative Care, University Hospital Wuppertal, Germany., Kausche L; Medical Department of Hematology and Oncology, Kepler University Hospital, Johannes Kepler University, Linz, Austria., Link H; Consultation Hematology and Oncology and Onkodin GmbH, Kaiserslautern, Germany., Mellinghoff SC; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Schmidt-Hieber M; Clinic of Hematology, Oncology, Pneumology, Nephrology and Diabetology, Medical University Lausitz - Carl Thiem (MUL-CT), Cottbus, Germany., Schuelper N; Department of Internal Medicine, Oncology and Palliative Medicine, medius KLINIKEN, Ostfildern, Germany., Spiekermann K; Department of Medicine III, University Hospital, LMU Munich, Bavarian Cancer Research Center (BZKF), Munich, Germany., Sprute R; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany; Department I of Internal Medicine, University of Cologne, Cologne, Germany., Seggewiss-Bernhardt R; Department of Hematology and Oncology, Sozialstiftung Bamberg, Bamberg, Germany; Comprehensive Cancer Center Mainfranken (CCC MF), University Hospital of Würzburg, Würzburg, Germany.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Feb 25; Vol. 235, pp. 116244. Date of Electronic Publication: 2026 Jan 16.
Publication Type: Journal Article; Practice Guideline
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41570611
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sandherr+M%22">Sandherr M</searchLink>; German Society of Hematology and Medical Oncology (DGHO), Berlin, Germany. Electronic address: sandherr@dgho.de.<br /><searchLink fieldCode="AU" term="%22Schalk+E%22">Schalk E</searchLink>; Department of Hematology Oncology and Cell Therapy, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany.<br /><searchLink fieldCode="AU" term="%22Heinz+WJ%22">Heinz WJ</searchLink>; Universtity of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Köhler+P%22">Köhler P</searchLink>; University of Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Krause+SW%22">Krause SW</searchLink>; Department of Medicine 5 - Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Liss+B%22">Liss B</searchLink>; Department of Hematology and Oncology, Infectious Diseases and Palliative Care, University Hospital Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Kausche+L%22">Kausche L</searchLink>; Medical Department of Hematology and Oncology, Kepler University Hospital, Johannes Kepler University, Linz, Austria.<br /><searchLink fieldCode="AU" term="%22Link+H%22">Link H</searchLink>; Consultation Hematology and Oncology and Onkodin GmbH, Kaiserslautern, Germany.<br /><searchLink fieldCode="AU" term="%22Mellinghoff+SC%22">Mellinghoff SC</searchLink>; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Schmidt-Hieber+M%22">Schmidt-Hieber M</searchLink>; Clinic of Hematology, Oncology, Pneumology, Nephrology and Diabetology, Medical University Lausitz - Carl Thiem (MUL-CT), Cottbus, Germany.<br /><searchLink fieldCode="AU" term="%22Schuelper+N%22">Schuelper N</searchLink>; Department of Internal Medicine, Oncology and Palliative Medicine, medius KLINIKEN, Ostfildern, Germany.<br /><searchLink fieldCode="AU" term="%22Spiekermann+K%22">Spiekermann K</searchLink>; Department of Medicine III, University Hospital, LMU Munich, Bavarian Cancer Research Center (BZKF), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Sprute+R%22">Sprute R</searchLink>; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany; Department I of Internal Medicine, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Seggewiss-Bernhardt+R%22">Seggewiss-Bernhardt R</searchLink>; Department of Hematology and Oncology, Sozialstiftung Bamberg, Bamberg, Germany; Comprehensive Cancer Center Mainfranken (CCC MF), University Hospital of Würzburg, Würzburg, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2026 Feb 25; Vol. 235, pp. 116244. <i>Date of Electronic Publication: </i>2026 Jan 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Practice Guideline
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41570611
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2026.116244
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 116244
    Titles:
      – TitleFull: Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sandherr M
      – PersonEntity:
          Name:
            NameFull: Schalk E
      – PersonEntity:
          Name:
            NameFull: Heinz WJ
      – PersonEntity:
          Name:
            NameFull: Köhler P
      – PersonEntity:
          Name:
            NameFull: Krause SW
      – PersonEntity:
          Name:
            NameFull: Liss B
      – PersonEntity:
          Name:
            NameFull: Kausche L
      – PersonEntity:
          Name:
            NameFull: Link H
      – PersonEntity:
          Name:
            NameFull: Mellinghoff SC
      – PersonEntity:
          Name:
            NameFull: Schmidt-Hieber M
      – PersonEntity:
          Name:
            NameFull: Schuelper N
      – PersonEntity:
          Name:
            NameFull: Spiekermann K
      – PersonEntity:
          Name:
            NameFull: Sprute R
      – PersonEntity:
          Name:
            NameFull: Seggewiss-Bernhardt R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 02
              Text: 2026 Feb 25
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0852
          Numbering:
            – Type: volume
              Value: 235
          Titles:
            – TitleFull: European journal of cancer (Oxford, England : 1990)
              Type: main
ResultId 1